NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

阿茲海默症治療的全球市場(2020年∼2030年):Covid-19造成的成長變化

Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 974569
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
阿茲海默症治療的全球市場(2020年∼2030年):Covid-19造成的成長變化 Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球阿茲海默症治療市場的相關調查,市場規模與預測,趨勢,策略,佔有率,成長及阻礙因素,各藥物類型、藥物類別、地區/國家的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長

  • 全球市場(2015-2019)
    • 市場成長要素
    • 阻礙市場要素
  • 全球市場預測(2019-2023F,2025F,2030F)

第4章 市場區隔

  • 全球市場及預測:各類藥物(2015-2019,2023F,2025F,2030F)
  • 膽鹼工作性
  • Memantine
  • 並用藥
  • AChE抑制劑
  • 免疫球蛋白
  • 全球市場及預測:各藥物類型(2015-2019,2023F,2025F,2030F)
  • 膽鹼酯酶抑制劑
  • NMDA受體拮抗劑

第5章 各地區/國家分析

  • 全球市場及預測:各地區(2015-2019,2023F,2025F,2030F)
  • 全球市場及預測:各國(2015-2019,2023F,2025F,2030F)

第6章 亞太地區

第7章 中國

第8章 印度

第9章 日本

第10章 澳洲

第11章 印尼

第12章 韓國

第13章 西歐

第14章 英國

第15章 德國

第16章 法國

第17章 東歐

第18章 俄羅斯

第19章 北美

第20章 美國

第21章 南美

第22章 巴西

第23章 中東

第24章 非洲

第25章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Allergan
    • Eisai Co. Ltd.
    • Novartis AG
    • Pfizer Inc.
    • Merz Pharma

第26章 主要合併和收購

第27章 市場趨勢與策略

第28章 市場未來展望和潛力分析

第29章 附錄

目錄

“Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth And Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global alzheimer's disease treatment market.

This report focuses on alzheimer's disease treatment market which is experiencing strong growth. The report gives a guide to the alzheimer's disease treatment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the alzheimer's disease treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward?“ The Alzheimer's Disease Treatment market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider alzheimer's disease treatment market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The alzheimer's disease treatment market section of the report gives context. It compares the alzheimer's disease treatment market with other segments of the alzheimer's disease treatment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, alzheimer's disease treatment indicators comparison.

Scope

Markets Covered:

  • 1) By Drug Class: Cholinergic; Memantine; Combined Drug; AChE inhibitors; Immunoglobulins
  • 2) By Drug Type: Cholinesterase Inhibitors; NMDA Receptor Antagonists
  • Companies Mentioned: Allergan; Eisai Co. Ltd.; Novartis AG; Pfizer Inc.; Merz Pharma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Alzheimer's Disease Treatment Market Characteristics

3. Alzheimer's Disease Treatment Market Size And Growth

  • 3.1. Global Alzheimer's Disease Treatment Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Alzheimer's Disease Treatment Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Alzheimer's Disease Treatment Market Segmentation

  • 4.1. Global Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cholinergic
  • Memantine
  • Combined Drug
  • AChE inhibitors
  • Immunoglobulins
  • 4.2. Global Alzheimer's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists

5. Alzheimer's Disease Treatment Market Regional And Country Analysis

  • 5.1. Global Alzheimer's Disease Treatment Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Alzheimer's Disease Treatment Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Alzheimer's Disease Treatment Market

  • 6.1. Asia-Pacific Alzheimer's Disease Treatment Market Overview
  • 6.2. Asia-Pacific Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Alzheimer's Disease Treatment Market

  • 7.1. China Alzheimer's Disease Treatment Market Overview
  • 7.2. China Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Alzheimer's Disease Treatment Market

  • 8.1. India Alzheimer's Disease Treatment Market Overview
  • 8.2. India Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Alzheimer's Disease Treatment Market

  • 9.1. Japan Alzheimer's Disease Treatment Market Overview
  • 9.2. Japan Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Alzheimer's Disease Treatment Market

  • 10.1. Australia Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Alzheimer's Disease Treatment Market

  • 11.1. Indonesia Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Alzheimer's Disease Treatment Market

  • 12.1. South Korea Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Alzheimer's Disease Treatment Market

  • 13.1. Western Europe Alzheimer's Disease Treatment Market Overview
  • 13.2. Western Europe Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Alzheimer's Disease Treatment Market

  • 14.1. UK Alzheimer's Disease Treatment Market Overview
  • 14.2. UK Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Alzheimer's Disease Treatment Market

  • 15.1. Germany Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Alzheimer's Disease Treatment Market

  • 16.3. France Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Alzheimer's Disease Treatment Market

  • 17.1. Eastern Europe Alzheimer's Disease Treatment Market Overview
  • 17.2. Eastern Europe Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Alzheimer's Disease Treatment Market

  • 18.1. Russia Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Alzheimer's Disease Treatment Market

  • 19.1. North America Alzheimer's Disease Treatment Market Overview
  • 19.2. North America Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Alzheimer's Disease Treatment Market

  • 20.1. USA Alzheimer's Disease Treatment Market Overview
  • 20.2. USA Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Alzheimer's Disease Treatment Market

  • 21.1. South America Alzheimer's Disease Treatment Market Overview
  • 21.2. South America Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Alzheimer's Disease Treatment Market

  • 22.1. Brazil Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Alzheimer's Disease Treatment Market

  • 23.1. Middle East Alzheimer's Disease Treatment Market Overview
  • 23.2. Middle East Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Alzheimer's Disease Treatment Market

  • 24.1. Africa Alzheimer's Disease Treatment Market Overview
  • 24.2. Africa Alzheimer's Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Alzheimer's Disease Treatment Market Competitive Landscape And Company Profiles

  • 25.1. Alzheimer's Disease Treatment Market Competitive Landscape
  • 25.2. Alzheimer's Disease Treatment Market Company Profiles
    • 25.2.1. Allergan
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Eisai Co. Ltd.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Pfizer Inc.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Merz Pharma
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Alzheimer's Disease Treatment Market

27. Alzheimer's Disease Treatment Market Trends And Strategies

28. Alzheimer's Disease Treatment Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer